Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 2698826)

Published in J Biol Eng on June 02, 2009

Authors

Yuning Lei1, Kye-Il Joo, Pin Wang

Author Affiliations

1: Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, California 90089, USA.

Articles cited by this

Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science (2002) 17.71

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science (1994) 13.54

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med (2007) 11.80

Acidification of the endocytic and exocytic pathways. Annu Rev Biochem (1986) 10.90

Visualization of the intracellular behavior of HIV in living cells. J Cell Biol (2002) 6.59

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47

Gene therapy -- promises, problems and prospects. Nature (1997) 6.02

Characterization of a human B lymphocyte-specific antigen. J Immunol (1980) 5.76

A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02

Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell (1985) 4.84

Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol (2006) 4.16

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science (1994) 3.97

Engineering targeted viral vectors for gene therapy. Nat Rev Genet (2007) 3.69

Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 2.74

A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma. Annu Rev Med (2008) 2.44

The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol (1999) 2.28

Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther (2005) 2.21

Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med (2005) 1.93

Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci U S A (1995) 1.80

Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci U S A (2006) 1.71

A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proc Natl Acad Sci U S A (1989) 1.64

Antibody-directed targeting of retroviral vectors via cell surface antigens. J Virol (2001) 1.50

Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci U S A (1999) 1.48

A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther (2000) 1.43

Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci U S A (1995) 1.32

Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins. J Virol (1996) 1.28

Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Gene Ther (2007) 1.27

Retargeting gene delivery using surface-engineered retroviral vector particles. Curr Opin Biotechnol (2001) 1.20

Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol (2003) 1.19

Targeting of retroviral vectors through protease-substrate interactions. Gene Ther (1996) 1.15

A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther (2007) 1.13

Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. Hum Gene Ther (1996) 1.03

Lentiviral vectors ready for prime-time. Nat Biotechnol (2007) 0.97

Visualization of targeted transduction by engineered lentiviral vectors. Gene Ther (2008) 0.97

Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope. Virology (2006) 0.97

Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum Gene Ther (2008) 0.96

Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J Gene Med (2008) 0.96

Molecular evidence of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors. Virology (2004) 0.90

Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting. Biotechnol Bioeng (2008) 0.84

Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumors. Mol Ther (2004) 0.80

Articles by these authors

MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol (2009) 3.72

Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol (2008) 2.05

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem (2011) 1.88

MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J Immunol (2010) 1.74

Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci U S A (2006) 1.71

Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J (2009) 1.25

Quantification of nanoscale nuclear refractive index changes during the cell cycle. J Biomed Opt (2011) 1.25

A designed phenylalanyl-tRNA synthetase variant allows efficient in vivo incorporation of aryl ketone functionality into proteins. J Am Chem Soc (2002) 1.22

Immunization delivered by lentiviral vectors for cancer and infectious diseases. Immunol Rev (2011) 1.18

EUS-guided transhepatic cholangiography: report of 6 cases. Gastrointest Endosc (2005) 1.15

Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood (2008) 1.14

REST regulates DYRK1A transcription in a negative feedback loop. J Biol Chem (2011) 1.14

Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages. Mol Immunol (2008) 1.06

Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology (2013) 1.04

Site-specific labeling of enveloped viruses with quantum dots for single virus tracking. ACS Nano (2008) 1.02

Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity. Mol Pharm (2014) 0.98

HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proc Natl Acad Sci U S A (2009) 0.98

Discovery and characterization of a group of fungal polycyclic polyketide prenyltransferases. J Am Chem Soc (2012) 0.98

Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs. Biomaterials (2013) 0.98

Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases. Mol Ther (2011) 0.97

Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity. Vaccine (2010) 0.96

Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum Gene Ther (2008) 0.96

Protein nanocapsule weaved with enzymatically degradable polymeric network. Nano Lett (2009) 0.95

A functional polymorphism in the TIM-1 gene is associated with asthma in a Chinese Han population. Int Arch Allergy Immunol (2007) 0.94

PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines. Mol Ther (2012) 0.93

Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials (2011) 0.93

Nuclear nano-morphology markers of histologically normal cells detect the "field effect" of breast cancer. Breast Cancer Res Treat (2012) 0.93

Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis. Expert Opin Pharmacother (2013) 0.92

Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J Mol Cell Cardiol (2010) 0.91

CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model. J Immunol (2008) 0.90

Genome mining of a prenylated and immunosuppressive polyketide from pathogenic fungi. Org Lett (2013) 0.90

Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates. ACS Nano (2011) 0.90

Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity. Hum Gene Ther (2009) 0.90

Altered resting brain function and structure in professional badminton players. Brain Connect (2012) 0.90

Design of a bacterial host for site-specific incorporation of p-bromophenylalanine into recombinant proteins. J Am Chem Soc (2006) 0.87

Batch fabrication of high-performance planar patch-clamp devices in quartz. Adv Mater (2010) 0.87

Pulsatile shear stress increased mitochondrial membrane potential: implication of Mn-SOD. Biochem Biophys Res Commun (2009) 0.86

Event-related potential effects of superior action anticipation in professional badminton players. Neurosci Lett (2011) 0.86

Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice. PLoS One (2012) 0.85

Synthetic niches for differentiation of human embryonic stem cells bypassing embryoid body formation. J Biomed Mater Res B Appl Biomater (2013) 0.85

Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule. Virol J (2010) 0.84

Endoprotease-mediated intracellular protein delivery using nanocapsules. ACS Nano (2011) 0.84

Clickable protein nanocapsules for targeted delivery of recombinant p53 protein. J Am Chem Soc (2014) 0.84

Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting. Biotechnol Bioeng (2008) 0.84

Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall-cell lung cancer. Genes Chromosomes Cancer (2012) 0.84

Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins. Microsc Res Tech (2010) 0.83

Type I IFN inhibits innate IL-10 production in macrophages through histone deacetylase 11 by downregulating microRNA-145. J Immunol (2013) 0.83

Regulator of calcineurin 1 gene transcription is regulated by nuclear factor-kappaB. Curr Alzheimer Res (2014) 0.83

An autosomal dominant cataract locus mapped to 19q13-qter in a Chinese family. Mol Vis (2011) 0.82

Introduction of an aliphatic ketone into recombinant proteins in a bacterial strain that overexpresses an editing-impaired leucyl-tRNA synthetase. Chembiochem (2009) 0.82

A functional polymorphism in the SPINK5 gene is associated with asthma in a Chinese Han Population. BMC Med Genet (2009) 0.82

Estrogen supplementation to progesterone as luteal phase support in patients undergoing in vitro fertilization: systematic review and meta-analysis. Medicine (Baltimore) (2015) 0.82

Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery. Biomed Res Int (2013) 0.82

Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy. Curr Pharm Des (2015) 0.81

Visualization of DC-SIGN-mediated entry pathway of engineered lentiviral vectors in target cells. PLoS One (2013) 0.81

Expectation enhances event-related responses to affective stimuli. Neurosci Lett (2012) 0.81

Lentiviral vectors for immune cells targeting. Immunopharmacol Immunotoxicol (2010) 0.81

Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule. Biotechnol Bioeng (2009) 0.81

Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins. Virus Res (2011) 0.81

Probing protease activity by single-fluorescent-protein nanocapsules. Chem Commun (Camb) (2010) 0.80

In vitro differentiation of adult bone marrow progenitors into antigen-specific CD4 helper T cells using engineered stromal cells expressing a notch ligand and a major histocompatibility complex class II protein. Stem Cells Dev (2009) 0.80

Construction of stable producer cells to make high-titer lentiviral vectors for dendritic cell-based vaccination. Biotechnol Bioeng (2012) 0.79

Incorporation of quantum dots on virus in polycationic solution. Int J Nanomedicine (2006) 0.79

A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses. Vaccine (2012) 0.79

LDL receptor knock-out mice show impaired spatial cognition with hippocampal vulnerability to apoptosis and deficits in synapses. Lipids Health Dis (2014) 0.79

Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. Eur Neurol (2014) 0.79

A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cells. J Vis Exp (2013) 0.79

Site-specific modification of adeno-associated viruses via a genetically engineered aldehyde tag. Small (2012) 0.78

[Protective effect of electroacupuncture intervention on neurovascular unit in rats with focal cerebral ischemia-reperfusion injury]. Zhen Ci Yan Jiu (2013) 0.78

Cell type-specific targeting with surface-engineered lentiviral vectors co-displaying OKT3 antibody and fusogenic molecule. Pharm Res (2009) 0.78

Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells. J Biol Eng (2011) 0.78

Xylose-fermenting Pichia stipitis by genome shuffling for improved ethanol production. Microb Biotechnol (2014) 0.78

Virus-receptor mediated transduction of dendritic cells by lentiviruses enveloped with glycoproteins derived from Semliki Forest virus. PLoS One (2011) 0.77

[Clinical analysis of 47 patients with psoriasis arthropathy treated by traditional Chinese medicine syndrome differentiation and integrative medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2008) 0.77

In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice. Biomacromolecules (2014) 0.77

Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells. Hum Gene Ther (2011) 0.76

Advanced glycation end product-induced astrocytic differentiation of cultured neurospheres through inhibition of Notch-Hes1 pathway-mediated neurogenesis. Int J Mol Sci (2013) 0.76

Antibody-mimetic ligand selected by mRNA display targets DC-SIGN for dendritic cell-directed antigen delivery. ACS Chem Biol (2013) 0.76

Serum insulin degrading enzyme level and other factors in type 2 diabetic patients with mild cognitive impairment. Curr Alzheimer Res (2016) 0.76

Dynamic variability of the heading-flowering stages of single rice in China based on field observations and NDVI estimations. Int J Biometeorol (2014) 0.75

Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization. Hum Gene Ther Methods (2014) 0.75